Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
| Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma. | Cancer Discov | 2023 | 37378557 | PubTator, text mining | PubMed |
| The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer. | Viruses | 2023 | 37376596 | PubTator, text mining | PubMed |
| Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context. | Gastroenterol Rep (Oxf) | 2023 | 37360193 | PubTator, text mining | PubMed |
| Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer. | Chin Med | 2023 | 37355637 | PubTator, text mining | PubMed |
| Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients. | J Exp Clin Cancer Res | 2023 | 37353792 | PubTator, text mining | PubMed |
| Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. | J Immunol | 2023 | 37350632 | PubTator, text mining | PubMed |
| A retrospective study of air quality associated with teratogenic pathogen screening in women of reproductive age in southern China. | Environ Sci Pollut Res Int | 2023 | 37347331 | PubTator, text mining | PubMed |
| Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer. | Front Immunol | 2023 | 37346034 | PubTator, text mining | PubMed |
| Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia. | Haematologica | 2023 | 37345470 | PubTator, text mining | PubMed |
| Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes. | J Exp Med | 2023 | 37341991 | PubTator, text mining | PubMed |
| Multicellular communities are perturbed in the aging human brain and Alzheimer's disease. | Nat Neurosci | 2023 | 37336975 | PubTator, text mining | PubMed |
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
| Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer. | Cell Rep | 2023 | 37330910 | PubTator, text mining | PubMed |
| Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA. | Front Oncol | 2023 | 37324016 | PubTator, text mining | PubMed |
| Recurrent infection transiently expands human tissue T cells while maintaining long-term homeostasis. | J Exp Med | 2023 | 37314481 | PubTator, text mining | PubMed |
| PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer. | Clin Transl Med | 2023 | 37313656 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| Recent advances and challenges in primary central nervous system lymphoma: a narrative review. | Transl Cancer Res | 2023 | 37304530 | PubTator, text mining | PubMed |
| Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies. | Int J Mol Sci | 2023 | 37298069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=25